Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
+506K
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$6.6M
-
Put/Call ratio
-
0.64
-
Number of buys
-
159
-
Number of sells
-
-131
-
Price
-
$11.69
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q3 2025
355 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q3 2025.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (13.3M shares), ARK Investment Management LLC (11.9M shares), BlackRock, Inc. (9.46M shares), FMR LLC (8.46M shares), MILLENNIUM MANAGEMENT LLC (5.44M shares), Sumitomo Mitsui Trust Group, Inc. (5.38M shares), Amova Asset Management Americas, Inc. (5.38M shares), WELLINGTON MANAGEMENT GROUP LLP (4.29M shares), Quantinno Capital Management LP (3.49M shares), and BANK OF AMERICA CORP /DE/ (3.41M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.